Mandate

Vinge advises KKR in the acquisition of Hyperion from Sandvik

December 12, 2017 M&A Carve-Outs

Vinge is advising the listed US investment fund KKR on its acquisition of Hyperion, a manufacturer of industrial tool components, from Sandvik.

Hyperion has 1400 employees in a number of jurisdictions and about SEK 3.2 billion in turnover. The transaction is expected to close during the first half of 2018 and is subject to customary completion conditions such as merger filing approvals.

Vinge’s team has consisted of Christina Kokko, Kristina Ekberg, Alex Miler, Marith Welin-Berger and Matthias Pannier (M&A/Corporate), Eva Fredriksson, Mathilda Persson (TSA/IT), Tobias Kempas, Ilze Lukins, Sophia Holm (IP), Kristoffer Larson (real estate), Sara Strandberg (employment law) and Johan Cederlund and Hedvig Ekdahl (environmental).

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026